London and Bristol, UK. 5 September 2023 - Amber Therapeutics (‘Amber’ or the ‘Company’) announces it has acquired Bioinduction Limited (‘Bioinduction’) and its Picostim DyNeuMo neuromodulation ...
Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive ...
MINNEAPOLIS, Sept. 16, 2025 /PRNewswire/ -- ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, today announced ...
Dublin, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Global Market- Forecast To 2029" report has been added to ResearchAndMarkets.com's offering. The neuromodulation global market is ...
TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ -- Neurolief, a leading pioneer in neuromodulation technology, recently unveiled its pivotal multicenter RCT clinical study results for its Proliv™Rx brain ...
Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...
This post was co-authored by Abigail Ramos and Robert T. Muller, Ph.D. With the development of new neuro-technology and emerging research on the function of the brain, the treatment of mental illness ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Cardiac neuromodulation therapy resulted in significant reductions in systolic BP at 6 months in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback